NCT02863055 2025-09-19NEMOEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 2 Terminated37 enrolled
NCT01907100 2019-03-18Nintedanib (BIBF 1120) in MesotheliomaBoehringer IngelheimPhase 2/3 Terminated545 enrolled 15 charts